Doppler and Biological Second Trimester Placental Insufficiency Screening

NCT00465634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 235

Last updated 2013-08-09

No results posted yet for this study

Summary

To assess the role of uterine artery and maternal serum leptin and lipids and their combination in screening for pre-eclampsia and small-for-gestational-age (SGA) fetuses at 20-24 weeks of gestation

Conditions

  • Pre-Eclampsia
  • Fetal Growth Retardation
  • Placental Insufficiency

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Franck Perrotin, MD-PhD · Tours University Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465634 on ClinicalTrials.gov